MedTrace Logo

Vagus Nerve Stimulation for Myelopathy

NCT07660250 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-06-22

No results posted yet for this study

Summary

The objective of this study is to generate preliminary data to establish the feasibility and effectiveness of transauricular vagus nerve stimulation (taVNS) to improve post-operative outcomes of moderate to severe degenerative cervical myelopathy (DCM)

Conditions

  • Degenerative Cervical Myelopathy

Interventions

DEVICE

Vagus nerve stimulation (taVNS)

Vagus nerve stimulation - clip is attached to ear

DEVICE

Sham Stimulation

Clip will be attached to the ear, but no stimulation will be given.

Sponsors & Collaborators

Principal Investigators

  • Wilson Z Ray, MD · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-14
Primary Completion
2028-04-30
Completion
2028-05-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07660250 on ClinicalTrials.gov